In vivo intracellular signaling as a marker of antiangiogenic activity. [electronic resource]
Producer: 20011018Description: 7048-51 p. digitalISSN:- 0008-5472
- Androstadienes -- pharmacology
- Angiogenesis Inhibitors -- pharmacology
- Biomarkers, Tumor -- physiology
- Blotting, Western
- Endothelial Growth Factors -- pharmacology
- Endothelium, Vascular -- drug effects
- Enzyme Activation
- Enzyme Inhibitors -- pharmacology
- Flavonoids -- pharmacology
- Fluorescent Antibody Technique
- Humans
- Indoles -- pharmacology
- Liver Neoplasms -- blood supply
- Lymphokines -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Neovascularization, Pathologic -- drug therapy
- Oxindoles
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Propionates
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt
- Pyrroles -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptors, Growth Factor -- antagonists & inhibitors
- Receptors, Vascular Endothelial Growth Factor
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
- Wortmannin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.